How Does Merck & Co.’s Stock Performance Compare to Other Healthcare Stocks?
With a market capitalization of $307.3 billion, Merck & Co., Inc. (MRK) develops and markets a broad portfolio of human health pharmaceuticals and vaccines in areas such as oncology, infectious diseases, cardiometabolic disorders and immunology, along with a strong animal health business serving livestock and companion animals. Companies valued at more than $200 billion are…